Collegium Pharmaceutical
COLL
A$46.30
Share price
-0.52%
Change (1 day)
-3.04%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total debt
Total debt on the balance sheet as of March 2025 : A$1.28 Billion
According to Collegium Pharmaceutical 's latest financial reports the company's total debt is A$1.28 Billion. A company’s total debt is the sum of all current and non-current debts.
Collegium Pharmaceutical - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$1.38 B | 39.59% |
| 2023-12-31 | A$0.98 B | -5.03% |
| 2022-12-31 | A$1.04 B | 191.99% |
| 2021-12-31 | A$0.35 B | 2.95% |
| 2020-12-31 | A$0.34 B | 1024.09% |
| 2019-12-31 | A$30.84 M | 88.94% |
| 2018-12-31 | A$16.32 M | 761.69% |
| 2017-12-31 | A$1.89 M | -67.06% |
| 2016-12-31 | A$5.75 M | -38.5% |
| 2015-12-31 | A$9.35 M | -41.16% |
| 2014-12-31 | A$15.89 M | 1356.99% |
| 2013-12-31 | A$1.09 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Agile Therapeutics
AGRX | A$0.44 M | -99.97% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | A$3.90 B | 202.94% | 🇮🇪 Ireland |
 United Therapeutics UTHR | A$0.30 B | -76.31% | 🇺🇸 USA |
 KemPharm KMPH | A$35.26 M | -97.26% | 🇺🇸 USA |